
迪纳元昇
迪纳元昇
Biotech/Healthcare
Hangzhou DNA NanoRise Biotechnology Co., Ltd. specializes in nucleic acid nanocarrier technology and has one of the world’s earliest R&D teams to apply the technology in vivo.
Latest round: Series B (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.